Inactive Instrument

Other languages Hamlet Pharma AB (publ)

Equities

HAMLET B

SE0015661152

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Hamlet BioPharma AB Completes the First Part of A Controlled Clinical Trial in Patients with Bladder Pain Syndrome (Severe Pain in the Urinary Bladder)	May. 06
Hamlet BioPharma Secures Large Scale Alpha1 Peptide Production in an Agreement with Polypeptide Group	Apr. 18
Hamlet BioPharma Announces Commercial Collaborations with Top International Advisory Firms	Apr. 11
Hamlet BioPharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 22
Hamlet Biopharma Announces New Analyses of Clinical Data from Alpha1h Treated Patients with Bladder Cancer Detect A Strong Immune Response with Known Anti-Tumor Effects	Jan. 25
Hamlet Biopharma AB Announces Antimicrobial Peptide Therapy for Tuberculosis Infections	Dec. 20
Hamlet Biopharma's Continued Development of Brain Tumor Therapy	Dec. 06
Hamlet BioPharma Receives U.S. FDA Fast Track Designation for Alpha 1H for the Treatment of Non-Muscle Invasive Bladder Cancer	Nov. 29
Hamlet BioPharma AB Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 17
Hamlet BioPharma AB Reports Earnings Results for the Fourth Quarter Ended June 30, 2023	23-08-28
Hamlet BioPharma AB Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-28
Hamlet Pharma Announces FDA Clearance of IND Application for Alpha1H for the Treatment of Non-Muscle Invasive Bladder Cancer	23-07-01
Hamlet Pharma Announces CEO Changes	23-06-30
Hamlet Pharma Secures Long-Term Alpha1 Peptide Production in an Agreement with Polypeptide Group	23-06-12
Hamlet Pharma Secures New Alpha1H Production Batch for Continued Clinical Trials	23-05-31
Hamlet Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-26
Hamlet BioPharma AB (NGM:HAMLET B) completed the acquisition of Selectimmune Pharma AB.	23-05-16
Hamlet Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-23
Hamlet Pharma AB Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-11
Hamlet Pharma AB Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Hamlet Pharma AB (publ)

Equities

HAMLET B

SE0015661152

Other languages

Filters